Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon K Cheng

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Velocity-based Adaptive Registration and Fusion for Fractionated Stereotactic Radiosurgery Using the Small Animal Radiation Research PlatformPaul J Black, Deborah R Smith, Kunal Chaudhary, et al.
Journal of Neuro-Oncology|August 14, 2019
Extent of resection and survival for oligodendroglioma: a U.S. population-based studyConnor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Neuro-Oncology|April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Journal of Neuro-Oncology|November 25, 2017
Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent diseaseTavish Nanda, Andrew Yaeh, Cheng-Chia Wu, et al.
ACS Chemical Biology|January 4, 2020
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis InducersLing F Ye, Kunal R Chaudhary, Fereshteh Zandkarimi, et al.
Journal of Neuro-Oncology|November 30, 2015
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgeryChristopher S Grubb, Ashish Jani, Cheng-Chia Wu, et al.
CNS Oncology|February 3, 2018
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastasesCheng-Hung Tai, Cheng-Chia Wu, Mark E Hwang, et al.
JAMA Oncology|May 18, 2023
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating ChemotherapyConnor J Kinslow, Ann Mercurio, Prashanth Kumar, et al.
Neuro-Oncology|June 29, 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomasConnor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted GliomasConnor J Kinslow, Ali I Rae, Kekoa Taparra, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Velocity-based Adaptive Registration and Fusion for Fractionated Stereotactic Radiosurgery Using the Small Animal Radiation Research PlatformPaul J Black, Deborah R Smith, Kunal Chaudhary, et al.
Journal of Neuro-Oncology|August 14, 2019
Extent of resection and survival for oligodendroglioma: a U.S. population-based studyConnor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Neuro-Oncology|April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Journal of Neuro-Oncology|November 25, 2017
Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent diseaseTavish Nanda, Andrew Yaeh, Cheng-Chia Wu, et al.
ACS Chemical Biology|January 4, 2020
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis InducersLing F Ye, Kunal R Chaudhary, Fereshteh Zandkarimi, et al.
Journal of Neuro-Oncology|November 30, 2015
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgeryChristopher S Grubb, Ashish Jani, Cheng-Chia Wu, et al.
CNS Oncology|February 3, 2018
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastasesCheng-Hung Tai, Cheng-Chia Wu, Mark E Hwang, et al.
JAMA Oncology|May 18, 2023
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating ChemotherapyConnor J Kinslow, Ann Mercurio, Prashanth Kumar, et al.
Neuro-Oncology|June 29, 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomasConnor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted GliomasConnor J Kinslow, Ali I Rae, Kekoa Taparra, et al.
Pageof 7